HotHouse Therapeutics | $3,835,279 | (Dec 3, 2025)
minitap | $4,100,000 | (Dec 3, 2025)
Reema Health | $19,000,000 | (Dec 3, 2025)
Ori Biotech
United Kingdom
- London, England
- 18/01/2022
- Series B
- $100,000,000
Ori Biotech is a London- and New Jersey-based leader in CGT manufacturing technology that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalised, lifesaving treatments.
By fully automating and standardising CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing.
So complex manufacturing challenges can be put where they belong – in the past.
- Industry Automation Machinery Manufacturing
- Website https://oribiotech.com/
- LinkedIn https://www.linkedin.com/company/oribiotech-ltd/about/
Related People
Jason C. FosterFounder
United Kingdom -
London, England
Leveraging my commercial expertise and detailed knowledge of the UK, US and EU healthcare markets, I help build organizations that maximize the value of their products & services to improve health and achieve significant returns for investors.
Soxton.AI | $2,500,000 | (Dec 3, 2025)
Antares | $96,000,000 | (Dec 3, 2025)
Metri Bio | $5,000,000 | (Dec 3, 2025)
Quickture | $1,900,000 | (Dec 3, 2025)
Ripple Foods | $17,000,000 | (Dec 3, 2025)
LYRIC BIO | $6,600,000 | (Dec 3, 2025)
Ascentra | $2,000,000 | (Dec 3, 2025)
lizzyAI - AI interviews. Made human. | $5,000,000 | (Dec 3, 2025)
Trial Library | $10,000,000 | (Dec 3, 2025)